Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nebulization in Severe Preeclampsia
NCT07164326Not yet recruiting
- Sponsor
- Assiut University
- Start
- Oct 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
01
Overview
Randomised trial of dexmedetomidine in severe preeclampsia (2 arms), sponsored by Assiut University. Primary endpoint: Systolic blood pressure in response to endotracheal intubation. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
severe preeclampsia
Beyond the preview
Go deeper on NCT07164326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07164326.